Remsberg_015_smallCharles Remsberg, CEO Mr. Remsberg joined Tibion in late 2009 after serving for 3 years as CEO of Hocoma Inc., the U.S. sales and marketing arm of the privately held Swiss company Hocoma AG, best known for its clinic-based Lokomat® robotic gait orthosis that has helped thousands of American patients with spinal cord, stroke, traumatic brain injury and cerebral palsy to recover their ability to walk. Prior to that position, Mr. Remsberg was head of worldwide sales for Hocoma, and for more than 10 years, an executive of Biodex Medical Systems, Shirley, NY. At Biodex, he rose from product development manager to head of worldwide sales for the nation’s leading supplier of balance, gait, and joint rehabilitation systems.
Robert Horst, Chief Technology Officer & Cofounder Robert Horst is the cofounder and chief technology officer of Tibion Corporation where he has been designing products for robotic therapy and mobility enhancement. He has more than 30 years of experience in electronics, systems architecture and fault-tolerant computing from his tenure at Hewlett Packard, Tandem Computers, Compaq, 3ware, and Network Appliance. As a consultant, he has worked with several startup companies and served as an expert witness in patent litigation. Dr. Horst is an IEEE Fellow and currently holds over 70 U.S. Patents. He received a BSEE from Bradley University, an MSEE from the University of Illinois and a PhD in Computer Science from the University of Illinois.
Matt Murphy, Vice President, Engineering Matt Murphy joined Tibion from Varian Proton Therapy, where he was responsible for product strategy. Prior to Varian, he was vice president of operations and product development at Adept, a leading factory automation and vision-guided robotics supplier. Mr. Murphy was vice president of product marketing and vice president of platform engineering at ADAC Laboratories in Milpitas, CA, and has more than 25 years’ experience in engineering management at ETAK Inc. and Lockheed Research Laboratory. Mr. Murphy holds B.S. and M.S. degrees in electrical engineering from the University of Illinois.
Mel Snyder, Director of Marketing (consultant) Mel Snyder brings to Tibion more than 30 years of experience developing marketing and communications programs for medical and rehabilitation equipment, diagnostics, pharmaceutical, biotech and medical services companies. He founded ProClinica, a multinational healthcare-specialized marketing/communications firm with offices in New York, Brussels, Cologne and a Tokyo. Key clients of ProClinica included Schering, DuPont, Nestle, Abbott, Baxter, Boots, Pharmacia, Wyeth, Biodex, Novo and Hocoma. After a 1995 merger, he joined the antibody company Immunomedics as vice president of marketing and sales, and then vice president of market development at the specialty pharma MacroChem. In 2006, he re-started ProClinica as a network consultancy, and in that role serves Tibion as its marketing director.